Coya Therapeutics (COYA) Projected to Post Earnings on Tuesday

Coya Therapeutics (NASDAQ:COYAGet Free Report) is projected to post its quarterly earnings results before the market opens on Tuesday, March 18th. Analysts expect Coya Therapeutics to post earnings of ($0.32) per share for the quarter.

Coya Therapeutics Stock Up 0.2 %

NASDAQ:COYA opened at $6.49 on Friday. Coya Therapeutics has a 52 week low of $4.75 and a 52 week high of $10.69. The stock has a market capitalization of $108.43 million, a PE ratio of -9.98 and a beta of 0.31. The stock’s 50-day moving average price is $6.28 and its 200-day moving average price is $6.47.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Chardan Capital reaffirmed a “buy” rating and issued a $14.00 price target on shares of Coya Therapeutics in a research note on Thursday, February 6th. D. Boral Capital reaffirmed a “buy” rating and issued a $15.00 price target on shares of Coya Therapeutics in a research note on Monday, March 10th.

Get Our Latest Research Report on Coya Therapeutics

About Coya Therapeutics

(Get Free Report)

Coya Therapeutics, Inc, a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.

Featured Stories

Earnings History for Coya Therapeutics (NASDAQ:COYA)

Receive News & Ratings for Coya Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coya Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.